About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Experimental Drug Deals Effectively with Prostate Cancer Cells

by Medindia Content Team on August 15, 2006 at 10:13 AM
Font : A-A+

Experimental Drug Deals Effectively with Prostate Cancer Cells

An experimental RNA-based drug acts by using genetic material called targeting RNA, to enter cancer cells, and another type, called silencing RNA , to stop the expression of a protein that keeps the cells alive, thereby destroying prostate cancer cells leaving normal cells unharmed.

The drug, developed at Duke University Medical Center, uses one type of genetic material, called In tests in mice with prostate cancer, the drug shrank the size of their tumors by half, while the tumors in control mice that did not receive the drug continued to grow, said study co-author Bruce Sullenger, Ph.D., director of Duke's Translational Research Institute and chief of the Division of Experimental Surgery.

Advertisement

The mice showed no side effects from the treatment, Sullenger said.

Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Experimental Drug Deals Effectively with Prostate Cancer Cells Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests